^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Anal Carcinoma
    Regimen:DCF (5-fluorouracil + cisplatin + docetaxel)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Anal carcinoma: Principles of systemic therapy…Other Recommended Regimens…Modified DCF